Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO can be a frustrating condition for both patients and medical professionals, as it can take a long time to diagnose and treat. In this article, we will explore the medical abbreviation FUO and discuss the various causes, diagnosis, and treatment of this condition.
FUO is a medical abbreviation for fever of unknown origin. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. FUO is defined as a fever that has persisted for more than three weeks without an identifiable cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The condition is most common in elderly patients, but can occur in any age group. It is important to note that FUO is not a specific disease, but rather a diagnosis of exclusion. This means that the cause of the fever must be determined before a diagnosis of FUO can be made.
The exact cause of FUO is often unknown, but there are many potential causes. These include infections, autoimmune disorders, malignancies, and medications. Infections are the most common cause of FUO, with viral infections such as influenza, mononucleosis, and HIV being the most common. Bacterial infections, such as tuberculosis, can also cause FUO. Autoimmune disorders, such as lupus, can also cause FUO. Malignancies, such as lymphoma and leukemia, can also cause FUO. Finally, medications, such as certain antibiotics, can also cause FUO.
The diagnosis of FUO is often a long and frustrating process. It involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The first step in diagnosing FUO is to rule out other causes of fever. This includes testing for infections, autoimmune disorders, malignancies, and medications. If these tests are negative, a diagnosis of FUO can be made. The next step in diagnosing FUO is to identify any underlying cause. This may involve further testing, such as additional laboratory tests, imaging studies, or biopsies. Once the underlying cause is identified, treatment can be tailored to the specific condition.
The treatment of FUO depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed. If an autoimmune disorder is the cause, immunosuppressive medications may be prescribed. If a malignancy is the cause, chemotherapy may be prescribed. If a medication is the cause, the medication may be discontinued.
Fever of unknown origin (FUO) is a common medical condition in which a patient has a fever that cannot be explained by a known cause. It is a diagnosis of exclusion, meaning that all other possible causes of fever must be ruled out before FUO can be diagnosed. The exact cause of FUO is often unknown, but there are many potential causes. The diagnosis of FUO involves a thorough medical history and physical examination, as well as laboratory tests and imaging studies. The treatment of FUO depends on the underlying cause. FUO can be a frustrating condition for both patients and medical professionals, but with proper diagnosis and treatment, it can be managed effectively.
1.
Risk of a second cancer after early breast cancer is low, say new findings
2.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
3.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
4.
Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
5.
Eight Doctors Killed in Brazil's Horrifying Plane Crash
1.
Exercise Rehabilitation in Hematologic Disease Survivorship
2.
Obesity is a major risk factor for cancer
3.
Exposure Modeling for Bispecific Antibodies: Scientific Foundations and Clinical Implications
4.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
5.
Dormant Tumor Cell Biomarkers for Early Oncologic Surveillance
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Recognizing General Warning Signs of Cancer
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation